when you tie the knot

We’re developing a fast, accurate, and affordable molecular Covid-19 test to give everyone access to PCR lab-accuracy whenever and wherever they need it. We’re reimagining the future of diagnostic testing, for good.

*Pending FDA Emergency Use Authorization

Why a molecular test?

Molecular tests—like Detect and PCR lab tests—look for viral RNA (its genetic material). These kinds of tests can identify even small amounts of the virus because of a process known as “amplification,” which replicates snippets of RNA to make them much easier to find. This process helps detect the virus early—days before symptoms occur—as well as at the tail-end of infection. Antigen tests look only for proteins on the outside of the virus and don’t use amplification, so they have a higher risk of missing infection1 at those stages.2

fpo product image
In Development

Accurate

Creating the best consumer testing experience means ensuring Detect meets the bar for PCR-level lab accuracy, with clinically validated results.

Fast

Typical lab-based PCR tests require at least 24 hours—and sometimes several days—to receive results. We’re working on a test that requires no lab work, with results available in 1 hour. Nothing to mail, no waiting days to receive results.

Convenient

We’re designing our test for comfort, with a quick, shallow nostril swab. You’ll just need a Detect Hub and Test Kit.

Reliable

With our proprietary chemistry built into the Detect Cap, we’re building our platform to be both robust to the development of new SARS-CoV-2 variants and easy to adapt to new pathogens in the future.3 We're constantly monitoring new variants to maintain our test performance.

Scalable

We plan to deliver millions of tests per month in the second half of 2021.

Detect for all

Testing for everyone

Keep employees safe
Keep kids in school
Care for loved ones
Care for those in need
Company

The people behind Detect

Dr. Jonathan Rothberg shaking hands with President Obama
our founder

Jonathan Rothberg, PhD

Detect founder Dr. Jonathan Rothberg has a strong track record of building successful companies that solve important scientific challenges. He is best known for inventing and commercializing massively parallel DNA sequencing, which earned him a National Medal of Technology and Innovation from President Obama, the nation’s highest honor for technological achievement. He is the founder of multiple health technology companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI and, more recently Butterfly Network (the world’s most accessible and fastest-selling ultrasound device), Quantum-Si (the first single-molecule protein sequencing platform), and Hyperfine Research (the world’s first truly portable MRI machine).

Detect founder Dr. Jonathan Rothberg has a strong track record of building successful companies that solve important scientific challenges. He is best known for inventing and commercializing massively parallel DNA sequencing, which earned him a National Medal of Technology and Innovat...

Read More

 

Our Team

The Detect team brings together the best and brightest from molecular biology, consumer technology, high-volume manufacturing, and product design. We are motivated to solve the hardest problems and to save lives through technology.

Join us

This once-in-a-hundred-years pandemic has fundamentally changed the world. Our team has set out to solve the testing problem, help reopen society, and launch a new industry and a new human behavior: testing as part of daily life, accessible to everyone around the world. Covid-19 today, any pathogen tomorrow.

Dr. Jonathan Rothberg, Detect Founder

Detect when it's available

Stay in the loop